Assenagon Asset Management
NTUS

Assenagon Asset Management’s Natus Medical Inc NTUS Stock Holding History

Assenagon Asset Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-58,957
Closed -$1.4M – 1604
2021
Q4 		$1.4M Buy
58,957
+29,273
+99% +$722K ﹤0.01% 947
2021
Q3 		$744K Sell
29,684
-11,239
-27% -$286K ﹤0.01% 984
2021
Q2 		$1.06M Sell
40,923
-17,200
-30% -$468K ﹤0.01% 908
2021
Q1 		$1.49M Sell
58,123
-905
-2% -$23.2K 0.01% 795
2020
Q4 		$1.18M Sell
59,028
-132,682
-69% -$2.6M 0.01% 688
2020
Q3 		$3.28M Buy
191,710
+47,343
+33% +$895K 0.02% 469
2020
Q2 		$3.15M Buy
144,367
+87,367
+153% +$2M 0.02% 448
2020
Q1 		$1.32M Buy
+57,000
New +$1.66M 0.01% 450
2019
Q3 		– Sell
-32,100
Closed -$825K – 1136
2019
Q2 		$825K Buy
+32,100
New +$818K 0.01% 758

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Assenagon Asset Management's NTUS Position: Q1 2022 in Review

Assenagon Asset Management sold out of Natus Medical Inc (NTUS) in Q1 2022, closing a stake of 58,957 shares — an estimated $1.4M sold.

Assenagon Asset Management first reported a position in NTUS in Q2 2019 and held it in 9 quarters. The position peaked at $3.28M in Q3 2020. 172 funds tracked by Wall St. Rank hold NTUS as of Q1 2022.

  • Assenagon Asset Management reported no remaining Natus Medical Inc position as of Q1 2022 after selling out during the quarter.
  • Assenagon Asset Management sold 58,957 Natus Medical Inc shares in Q1 2022, an estimated $1.4M.
  • Assenagon Asset Management first reported a position in Natus Medical Inc in Q2 2019 and held it in 9 quarters.
  • Assenagon Asset Management's Natus Medical Inc position peaked at $3.28M in Q3 2020.
  • 172 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2022.

Based on Assenagon Asset Management's 13F filing for Q1 2022, filed 25 Apr 2022.